Does Dr. ROBERTO ALERS FERNANDEZ have financial conflicts of interest?

Dr. ROBERTO ALERS FERNANDEZ (M.D.) has received a total of $758 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $758 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROBERTO ALERS FERNANDEZ?

According to CMS Open Payments data, Dr. ROBERTO ALERS FERNANDEZ received funding from BOEHRINGER INGELHEIM PHARMACEUTICALS ($156), DEXCOM ($150), and BAYER HEALTHCARE PHARMACEUTICALS ($125).

Does Dr. ROBERTO ALERS FERNANDEZ receive research grants or speaking fees?

Dr. ROBERTO ALERS FERNANDEZ has received $758 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ROBERTO ALERS FERNANDEZ

M.D.Real-Time Hydrated

Specialty: Internal Medicine

Practice Location: AGUADILLA, PR 00603

NPI Number: 1417952649

LIFETIME INDUSTRY VALUE

$758

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALERS FERNANDEZ is a verified Internal Medicine practitioner based in AGUADILLA, PR.

Between 2021 and 2025, Dr. ALERS FERNANDEZ had an overall industry promotional and research financial footprint of $758 as recorded in the federal CMS Open Payments database.

$758 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALERS FERNANDEZ's primary funding source is BOEHRINGER INGELHEIM PHARMACEUTICALS, which accounts for $156 (representing 20.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 1

$156

20.6%

DEXCOM

Rank 2

$150

19.8%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 3

$125

16.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.